These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17351667)

  • 41. Sonic hedgehog improves ischemia-induced neovascularization by enhancing endothelial progenitor cell function in type 1 diabetes.
    Qin Y; He YH; Hou N; Zhang GS; Cai Y; Zhang GP; Xiao Q; He LS; Li SJ; Yi Q; Luo JD
    Mol Cell Endocrinol; 2016 Mar; 423():30-9. PubMed ID: 26773732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice.
    Robillard S; Mercier C; Breton V; Paquin-Veillette J; Guay A; Lizotte F; Geraldes P
    Diab Vasc Dis Res; 2020; 17(1):1479164119883978. PubMed ID: 31726870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melatonin Improves Ischemia-Induced Circulation Recovery Impairment in Mice with Streptozotocin-Induced Diabetes by Improving the Endothelial Progenitor Cells Functioning.
    Kuo CS; Chen CY; Huang HL; Tsai HY; Chou RH; Wei JH; Huang PH; Lin SJ
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression.
    Rossiello MR; Momi S; Caracchini R; Giannini S; Guglielmini G; Monopoli A; Ongini E; Semeraro N; Colucci M; Gresele P
    J Thromb Haemost; 2005 Nov; 3(11):2554-62. PubMed ID: 16241953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes.
    Thum T; Fraccarollo D; Schultheiss M; Froese S; Galuppo P; Widder JD; Tsikas D; Ertl G; Bauersachs J
    Diabetes; 2007 Mar; 56(3):666-74. PubMed ID: 17327434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells.
    Mangialardi G; Monopoli A; Ongini E; Spinetti G; Fortunato O; Emanueli C; Madeddu P
    Br J Pharmacol; 2011 Sep; 164(2b):570-83. PubMed ID: 21486281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydroxy-methylglutaryl-coenzyme A reductase inhibition improves endothelial dysfunction in type-1 diabetes.
    Joyce M; Moore K; Thompson C; Fitzgerald P; Fennessy F; Kelly CJ; Bouchier-Hayes DJ
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):432-7. PubMed ID: 15015196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis.
    Sumi M; Sata M; Miura S; Rye KA; Toya N; Kanaoka Y; Yanaga K; Ohki T; Saku K; Nagai R
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):813-8. PubMed ID: 17272742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow.
    Gertz K; Priller J; Kronenberg G; Fink KB; Winter B; Schröck H; Ji S; Milosevic M; Harms C; Böhm M; Dirnagl U; Laufs U; Endres M
    Circ Res; 2006 Nov; 99(10):1132-40. PubMed ID: 17038638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis.
    Sata M; Nishimatsu H; Osuga J; Tanaka K; Ishizaka N; Ishibashi S; Hirata Y; Nagai R
    Hypertension; 2004 Jun; 43(6):1214-20. PubMed ID: 15166180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
    Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
    Kobayashi T; Matsumoto T; Kamata K
    Br J Pharmacol; 2000 Sep; 131(2):231-8. PubMed ID: 10991915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Passive exercise using whole-body periodic acceleration enhances blood supply to ischemic hindlimb.
    Rokutanda T; Izumiya Y; Miura M; Fukuda S; Shimada K; Izumi Y; Nakamura Y; Araki S; Hanatani S; Matsubara J; Nakamura T; Kataoka K; Yasuda O; Kaikita K; Sugiyama S; Kim-Mitsuyama S; Yoshikawa J; Fujita M; Yoshiyama M; Ogawa H
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2872-80. PubMed ID: 21940947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MK-0626, a dipeptidyl peptidase-4 inhibitor, improves neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression.
    Shih CM; Chen YH; Lin YW; Tsao NW; Wu SC; Kao YT; Chiang KH; Li CY; Chang NC; Lin CY; Huang CY; Lin FY
    Curr Med Chem; 2014 Jun; 21(17):2012-22. PubMed ID: 24059225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ.
    Biscetti F; Pecorini G; Arena V; Stigliano E; Angelini F; Ghirlanda G; Ferraccioli G; Flex A
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):80-7. PubMed ID: 23891623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nitric oxide (NO)-releasing statin derivatives, a class of drugs showing enhanced antiproliferative and antiinflammatory properties.
    Ongini E; Impagnatiello F; Bonazzi A; Guzzetta M; Govoni M; Monopoli A; Del Soldato P; Ignarro LJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8497-502. PubMed ID: 15173604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice.
    Mitsuhashi T; Uemoto R; Ishikawa K; Yoshida S; Ikeda Y; Yagi S; Matsumoto T; Akaike M; Aihara KI
    J Atheroscler Thromb; 2018 Jan; 25(1):65-80. PubMed ID: 28592707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effects of nitric oxide dependent and independent vasodilation on impaired hindlimb revascularization in eNOS
    Martínez-Ruiz M; Vargas-Robles H; Rios A; Sánchez D; Escalante B
    Can J Physiol Pharmacol; 2019 May; 97(5):377-385. PubMed ID: 30624957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.